These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9490952)

  • 41. Optimal scan delay depending on contrast material injection duration in abdominal multi-phase computed tomography of pancreas and liver in normal Beagle dogs.
    Choi SY; Lee I; Seo JW; Park HY; Choi HJ; Lee YW
    J Vet Sci; 2016 Dec; 17(4):555-561. PubMed ID: 27297414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effective use of low-osmolality contrast media for CT of the liver: evaluation of liver enhancement provided by various doses of iohexol.
    Bree RL; Parisky YR; Bernardino ME; Costello P; Leder R; Brown PC
    AJR Am J Roentgenol; 1994 Sep; 163(3):579-83. PubMed ID: 8079849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic spiral CT: reduction of dose of intravenous contrast material.
    Brink JA; Heiken JP; Forman HP; Sagel SS; Molina PL; Brown PC
    Radiology; 1995 Oct; 197(1):83-8. PubMed ID: 7568859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrast-enhanced spiral CT of the liver: effect of injection time on time to peak hepatic enhancement.
    Irie T; Kusano S
    J Comput Assist Tomogr; 1996; 20(4):633-7. PubMed ID: 8708070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simplified split-bolus intravenous contrast injection technique for pediatric abdominal CT.
    Kim YH; Kim MJ; Shin HJ; Yoon H; Lee MJ
    Clin Imaging; 2017; 46():28-32. PubMed ID: 28688244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of scan delay on hepatic enhancement for pediatric abdominal multislice helical CT.
    Frush DP; Donnelly LF; Bisset GS
    AJR Am J Roentgenol; 2001 Jun; 176(6):1559-61. PubMed ID: 11373232
    [No Abstract]   [Full Text] [Related]  

  • 47. Optimal timing of abdominal CT in children: relationship to injection rate.
    Kuhns LR
    Radiology; 1993 Oct; 189(1):49-51. PubMed ID: 8372218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver CT: a practical approach to dynamic contrast enhancement.
    Ditchfield MR; Gibson RN; Fairlie N
    Australas Radiol; 1992 Aug; 36(3):210-3. PubMed ID: 1445103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic CT imaging: effects of different injection rates and doses of contrast material.
    Kim T; Murakami T; Takahashi S; Okada A; Hori M; Narumi Y; Nakamura H
    Radiology; 1999 Jul; 212(1):219-25. PubMed ID: 10405745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CT arterial portography of the abdomen: effect of injecting papaverine into the mesenteric artery on hepatic contrast enhancement.
    Soyer P; Lacheheb D; Levesque M
    AJR Am J Roentgenol; 1993 Jun; 160(6):1213-5. PubMed ID: 8498218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients.
    Chambers TP; Baron RL; Lush RM
    Radiology; 1994 Nov; 193(2):513-7. PubMed ID: 7972770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of catheter size and injection rate of contrast agent on enhancement and image quality for triple-phase helical computed tomography of the liver in small dogs.
    Lee SK; Lee D; Kim D; Cha A; Choi J
    Vet Radiol Ultrasound; 2017 Nov; 58(6):664-670. PubMed ID: 28752521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
    Vignaux O; Legmann P; Coste J; Hoeffel C; Bonnin A
    AJR Am J Roentgenol; 1999 Nov; 173(5):1193-7. PubMed ID: 10541087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of the time to peak hepatic enhancement to optimize contrast-enhanced spiral CT.
    Irie T; Suzuki S; Yamauchi T; Kusano S
    Acta Radiol; 1995 Mar; 36(2):154-8. PubMed ID: 7710795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic helical CT: effect of reduction of iodine dose of intravenous contrast material on hepatic contrast enhancement.
    Freeny PC; Gardner JC; vonIngersleben G; Heyano S; Nghiem HV; Winter TC
    Radiology; 1995 Oct; 197(1):89-93. PubMed ID: 7568860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
    Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
    AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement?
    Paulson EK; Fisher AJ; DeLong DM; Parker DD; Nelson RC
    Radiology; 1998 Dec; 209(3):787-92. PubMed ID: 9844675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Parameters influencing hepatic parenchyma enhancement in x-ray computed tomography after intravenous injection of iodinated contrast medium].
    Bonaldi VM; Garcia P; Bret PM
    J Radiol; 1997 Apr; 78(4):265-70. PubMed ID: 9239358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast material.
    Kopka L; Rodenwaldt J; Fischer U; Mueller DW; Oestmann JW; Grabbe E
    Radiology; 1996 Nov; 201(2):321-6. PubMed ID: 8888218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.